On March 14, 2022 Emergent BioSolutions Inc. (NYSE: EBS) reported that members of the company’s executive management team will participate in the following investor conferences (Press release, Emergent BioSolutions, MAR 14, 2022, View Source [SID1234610035]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

KeyBanc Life Sciences & MedTech Investor Forum
March 22, 2022
Company fireside chat scheduled for 1:30 pm eastern
View Source
BofA Securities 2022 Healthcare Conference
May 10, 2022
Presentation scheduled for 12:00 pm eastern
Goldman Sachs 7th Annual Leveraged Finance and Credit Conference
May 11 to 13, 2022
Presentation date and time will be updated on the Emergent website as the information becomes available.
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.